Duloxetine treatment adherence across mental health and chronic pain conditions
Stephen L Able,1 Zhanglin Cui,2, Wei Shen2 1Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USA; 2Global Statistical Sciences, Eli Lilly and Company, Indianapolis, IN, USA Purpose: This study applied a uniform methodology for measuring and comparing duloxetine adherence in the treat...
Saved in:
Main Authors: | Able SL (Author), Cui Z (Author), Shen W (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Duloxetine in the management of chronic musculoskeletal pain
by: Smith EJ, et al.
Published: (2012) -
A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic pain
by: King JB, et al.
Published: (2015) -
Role of Duloxetine as Adjuvant in Chemotherapy Induced Peripheral Neuropathic Pain-An Update
by: Kalpajit Dutta, et al.
Published: (2016) -
Comparison of the Efficacy of Duloxetine Versus Pregabalin for Pain Relief of Neuropathy in Diabetics
by: Hamid Raza Gulzar, et al.
Published: (2024) -
Effect of Pregabalin Combined with Duloxetine and Tramadol on Allodynia in Chronic Postischemic Pain and Spinal Nerve Ligation Mouse Models
by: Jie Quan, et al.
Published: (2022)